DIRS.INFO top alerts submit data jurnalism about API
login
Top related persons:
Lam - 1 Macy's - 1 Tony Spring - 1 Marvin Ellison - 1 BlackLine - 1 FactSet - 1 Keysight - 1 AutoZone - 1
Top related locs:
billings —
Top related orgs:
AstraZeneca — U.S - 1 Traffic Safety Administration - 1 Dell Technologies - 1 Citi - 1 Baird - 1 Palo Alto Networks - 1 Keysight - 1 EV - 1

Search resuls for: "BlackLine"


4 mentions found


☆ Stocks making the biggest moves midday: Peloton, Lam Research, Lowe's, AstraZeneca and more
  + stars: | 2024-05-21 | by ( Michelle Fox | ) www.cnbc.com   time to read: +4 min
Lowe's — The home improvement stock fell 2.9% despite the company posting a first-quarter earnings and revenue beat. By comparison, analysts surveyed by FactSet had penciled in $1.45 in earnings per share on $1.21 billion in revenue. XPeng — U.S-listed shares jumped nearly 5% after the Chinese EV company topped first-quarter estimates for revenue and said it anticipates a rise in quarterly deliveries. AutoZone reported $4.24 billion in revenue for the quarter, below the $4.29 billion expected by analysts, according to FactSet. Sprout Social — Shares dropped 4% after Sprout Social responded to a Reuters report, citing sources familiar, that said its founders are in talks to take the social media strategy company private.
Persons: Lam, Macy's, Tony Spring, Marvin Ellison, BlackLine, FactSet, Keysight, AutoZone, Li Auto, Li, Yun Li, Jesse Pound, Sarah Min, Alex Harring, Lisa Han, Samantha Subin Organizations: AstraZeneca — U.S, Traffic Safety Administration, Dell Technologies, Citi, Baird, Palo Alto Networks, Keysight, EV, Reuters, Li Auto Locations: billings, —
☆ Cramer's lighting round: Stay away from Blackline
  + stars: | 2023-01-04 | by ( Krystal Hur | ) www.cnbc.com   time to read: 1 min
Those are the ones I'm trying to get people to stay away from." Way too speculative. Loading chart...Oramed Pharmaceuticals Inc : "This thing has had way too big a move. It's way too speculative." Disclaimer: Cramer's Charitable Trust owns shares of Eli Lilly.
☆ Here are the 34 tech companies most likely to be snapped up by private equity firms like Vista and Thoma Bravo in 2023, according to bankers and market data
  + stars: | 2022-12-24 | by ( Ben Bergman | Stephanie Palazzolo | ) www.businessinsider.com   time to read: +22 min
With a stock price down 45% in the last year, though, it may soon find itself on the other side of the table. But it has $732 million in cash on hand, with zero debt, and analysts are projecting 16% revenue growth. This year, though, Varonis has come back to earth — its stock price has sunk over 57% in the last 12 months. However, with strong projected 2023 revenue growth of 18.6%, Zuora remains a strong target for PE firms. Its stock price has been hammered, going down about 40% this year and making it the subject of mergers-and-acquisitions chatter.
☆ Here are the 34 tech companies most likely to be on the holiday shopping lists of private-equity firms after valuations plunged this year, according to bankers and private data
  + stars: | 2022-12-15 | by ( Ben Bergman | Stephanie Palazzolo | ) www.businessinsider.com   time to read: +22 min
With a stock price down 45% in the last year, though, it may soon find itself on the other side of the table. But it has $732 million in cash on hand, with zero debt, and analysts are projecting 16% revenue growth. This year, though, Varonis has come back to earth — its stock price has sunk over 57% in the last 12 months. However, with strong projected 2023 revenue growth of 18.6%, Zuora remains a strong target for PE firms. Its stock price has been hammered, going down about 40% this year and making it the subject of mergers-and-acquisitions chatter.
0 next >>
Total: 4